Ovoca Bio plc (ISE:OVXA)

Ireland flag Ireland · Delayed Price · Currency is EUR
0.0105
0.00 (0.00%)
Feb 21, 2025, 9:05 AM GMT
110.00%
Market Cap 1.55M
Revenue (ttm) n/a
Net Income (ttm) -3.57M
Shares Out 81.56M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 47,765
Average Volume n/a
Open 0.0105
Previous Close 0.0105
Day's Range 0.0105 - 0.0105
52-Week Range 0.0050 - 0.0300
Beta 1.22
RSI 13.34
Earnings Date Jun 25, 2025

About Ovoca Bio

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It’s lead product is BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1985
Employees 5
Stock Exchange Euronext Dublin
Ticker Symbol OVXA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.